Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01879098 · ClinicalTrials.gov registry record · Phase 1

The Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation

A Phase 1 study, sponsored by University of Florida.

Completed
Registry status
Phase 1
Development phase
155
Enrollment target

NCT01879098 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 155 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01879098, a Phase 1 study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
Phase 1
Development phase
155 participants
Enrollment target

Study Summary

The purpose of this research study is to determine whether a probiotic can change the way bile is used by the body. The investigators will also look at the effect of the probiotic on your intestinal health.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT Bifidobacterium animalis
  • DIETARY_SUPPLEMENT Lactobacillus plantarum
  • DIETARY_SUPPLEMENT Probiotic: Bacillus subtilis

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2013-08
Est. Completion 2014-06
Phase Phase 1

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT01879098

The ClinicalTrials.gov registry entry for NCT01879098 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 155 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.

NCT01879098 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01879098 about?

NCT01879098 is a clinical study titled "The Effect of 3 Probiotic Strains on Bile Acids, Satiety, and Inflammation". The purpose of this research study is to determine whether a probiotic can change the way bile is used by the body. The investigators will also look at the effect of the probiotic on your intestinal health.

What is the current status of trial NCT01879098?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 155 participants. The study started on 2013-08. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01879098?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Bifidobacterium animalis (DIETARY_SUPPLEMENT), Lactobacillus plantarum (DIETARY_SUPPLEMENT), Probiotic: Bacillus subtilis (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01879098?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.